This brand name is authorized in Brazil, Estonia, Croatia, Ireland, Lithuania, Poland, Singapore
The drug DENGVAXIA contains a combination of these active pharmaceutical ingredients (APIs):
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07BX04 | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BX Other viral vaccines | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 576720030057817, 576720030057917, 576720030058017, 576720030058117, 576720030058217 |
| Country: EE | Ravimiamet | Identifier(s): 1786529, 1786530, 1786541 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1086818, 1086819, 1086820, 1086821, 1086822 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100416157 |
| Country: SG | Health Sciences Authority | Identifier(s): 15096P, 15097P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
